Article Text

Download PDFPDF
Letter to the editor: Helicobacter pylori eradication – the proof is not in the symptoms

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors JB, MP and PM have written and edited this document in equal contribution.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests JB: Consultancy funding from Mayoly Spindler laboratories. MP: Consultancy funding from Ipsen, Advanced Accelerator Applications, INFAI and Mayoly Spindler laboratories and research funding to investigate the role of netazepide in gastric NETs from Trio Medicines. PM: Speaker fees, advisory board member and consultancy for Bayer, Biohit, Biocodex, Danone, Mayoly, Malesci, Menarini and Phathom Pharamaceuticals.

  • Provenance and peer review Not commissioned; internally peer reviewed.